AMLX

Amylyx Pharmaceuticals

Fundamental data last updated:April 13, 2026

company profile

SECTOR

Healthcare

industry

Drug Manufacturers - Specialty & Generic

Exchange

Nasdaq

County of HQ

United States

Next Earnings Date

05/14/26

Business Summary

DT Midstream operates energy infrastructure assets that transport and process natural gas, earning predominantly fee-based revenue tied to volumes rather than direct commodity price exposure. The business model relies on long-lived pipeline and gathering assets that generate predictable cash flows once built, creating operating leverage as throughput rises. Its moat is rooted in regulated infrastructure, high replacement costs, and entrenched customer relationships that make competing pipelines economically irrational in many corridors. Cash generation comes from contracted capacity and throughput fees, supporting dividends and steady reinvestment into incremental expansions rather than speculative exploration.

VALUATION

P/E

-

Market Cap ($M USD)

$1,808

Forward P/E

-

PEG

-

PRICE TO SALES

-

PRICE TO BOOK

5.9

EV / EBITDA

-9.8

5-Year Average P/E

DIVIDEND

Yield

-

Annual Payout

-

Payout Ratio

-

Consecutive Years of Dividend Growth

0

5-Year Dividend Growth Rate

-

Financial Health & Profitability

Earnings Per Share

-$1.53

Next Year EPS Growth Estimate

-$1.23

Next Year Revenue Growth Estimate

-

Return on Equity (ROE)

-47.40%

Operating Margin

-

Debt-to-Equity

0

Piotroski F-Score

4

Altman Z-Score

36

Return on Invested Capital (ROIC)

-64.50%%

Current Ratio

14.3

Quick Ratio

Gainseekers Quantitative Analysis

Summary

At 31.6x earnings and 26.8x forward earnings, DTM is priced like a steady compounder, yet its 9.8 forward PEG screams overvaluation relative to growth. An Altman Z-Score of 2 places it in the gray zone, not distressed but far from fortress-level safety, especially for a capital-intensive midstream operator. With ROIC at 6.90% and Return on Equity at 6.10%, returns are modest, not premium, meaning the market is assigning a quality multiple to a business generating average economics. This is not a screaming mispricing; it looks like a fully valued utility-style asset with limited growth embedded in the current multiple.

AI Exposure / Tech Reliance

As an Oil & Gas Midstream operator, DTM sits in infrastructure, not high-tech innovation, meaning AI disruption risk is minimal but upside from tech leverage is limited. Optimization, predictive maintenance, and pipeline monitoring could marginally improve its 9.30% operating margin, but this is incremental, not transformational. The business is structurally tied to energy throughput volumes rather than digital disruption cycles.

The Bull Case

A GARP investor could justify owning this name on financial discipline and stability metrics. The Piotroski F-Score of 8 signals strong fundamental momentum and operational health, while a 6.90% ROIC exceeding many regulated infrastructure returns shows disciplined capital allocation. Operating margin of 9.30% in midstream reflects stable fee-based economics, and a Debt/Equity ratio of 49.40% is manageable for an asset-heavy pipeline operator. The 2.50% dividend with a 4% five-year average yield history adds income support, and institutional ownership at $141.57 suggests deep capital market participation. Combined with a Current Ratio of 1.1, liquidity is adequate, reinforcing a steady, income-oriented profile rather than a speculative energy bet.

The Bear Case

The bear case centers on valuation versus growth. A 9.8 PEG ratio is egregious for a company with Sales Growth Next Year listed at $5.07 and EPS Next Year at $4.34, implying the growth trajectory does not justify a 26.8 forward multiple. Return on Equity at 6.10% is uninspiring, especially when the P/E is above 30, signaling multiple compression risk. The Altman Z-Score of 2 leaves little room for operational shocks in a cyclical energy environment, and a Current Ratio of 1.1 offers limited liquidity cushion. With a TTM Yield of 0.7 and a Payout Ratio listed at $3.52, the income profile does not compensate for valuation risk, leaving investors exposed to de-rating without high growth to offset it.

Market Sentiment & Smart Money

Short Interest %

13.60%

Analyst Consensus

1.17

Average Analyst Price Target

$22.80

Institutional Ownership %

104.50%

1-Year Beta

1.22

Insider Buying % (6 Mo)

7.90%%

Distance to 52-Week High

93.50%%

Distance to 52-Week Low

478.40%%